Gastric Cancer Drugs Market - By Type (Imatnib, Trastuzumab), By End-User (Hospitals, Clinics Cancer Specialty Centers), By Route of Administration (Oral, Parental) And By Region, Opportunities And Strategies – Global Forecast To 2030

Starting Price : $5000.00 | Pages : 282 | Published : August 2021 | SKU CODE : o&s294 | Format :

Request Sample

Gastric Cancer Drugs Market Definition

The gastric cancer drugs market consists of sales of gastric cancer drugs and related services by entities (organizations, sole traders and partnerships) that produce gastric cancer drugs to prevent, diagnose and treat gastric cancer. This industry includes establishments that produce drugs used in chemotherapy, surgery and radio therapies for treating gastric cancer.

Gastric cancer, also known as stomach cancer, is a disease in which malignant (cancer) cells are formed on the lining of stomach resulting in stomach pain and indigestion.

The pharmaceutical industry develops drugs to diagnose, treat or prevent diseases. Pharmaceutical drugs are subjected to various laws and regulations that deal with patenting, testing, safety, efficacy and marketing. Gastric cancer drugs manufacturers produce pharmaceutical drugs made from active pharmaceutical ingredients (API) and excipients.

Gastric Cancer Drugs Market Size

The global gastric cancer drugs market reached a value of nearly $2,516.2 million in 2020, having decreased at a compound annual growth rate (CAGR) of -13.6% since 2015. The market is expected to grow from $2,516.2 million in 2020 to $3,914.8 million in 2025 at a rate of 9.2%. The gastric cancer drugs market is then expected to grow at a CAGR of 4.3% from 2025 and reach $4,832.0 million in 2030.  

Growth in the historic period in the gastric cancer drugs market resulted from increase in pharmaceutical R&D expenditure, increased healthcare expenditure, strong economic growth in emerging markets and rapid growth in elderly population. The market was restrained by patent expiration of drugs, pricing pressures from regulators, low healthcare access and challenges due to regulatory changes.

Going forward Increase in gastric cancer incidence rate, strong pipeline of drugs, rise in acquisitions and partnerships for drug development, rise in healthcare expenditure high potential in emerging economies, increasing geriatric population and revised FDA regulations to facilitate biologics drug development will drive the growth in the gastric cancer drugs market. Factors that could hinder the growth of the market in the future include high costs of drugs, the coronavirus pandemic and adverse effects of gastric cancer drugs.

Gastric Cancer Drugs Market Drivers

The key drivers of the gastric cancer drugs market included:

Increase in Gastric Cancer Incidence Rate

The rise in the number of gastric cancer cases across the globe is likely to contribute to the growth of the gastric cancer drugs market during the forecast period. According to the estimates stomach cancer is the fifth most commonly diagnosed cancer globally and approximately 27,600 new cases of stomach cancer will be diagnosed in the US in 2020. According to the American Cancer Society, it is estimated that there will be 26,560 new cases of stomach cancer and 11,180 deaths from gastric cancer in the United States in 2021. Therefore, the rise in gastric cancer incidence rate globally is anticipated to boost the demand for gastric cancer drugs over the forthcoming years.

Gastric Cancer Drugs Market Restraints

The key restraints on the gastric cancer drugs market include:

High Costs Of Drugs

High costs associated with gastric cancer treatment is a major issue faced by many countries. The pressure to contain costs and demonstrate value is widespread. Political uncertainty and persistent economic stress in numerous countries are calling into question the sustainability of public health care funding. As a result, in less wealthy countries such as Chad and Serbia, pharmaceutical companies are facing the pressure of reducing the price of drugs. The higher costs associated with drugs and treatment of gastric carcinomas are showing a direct effect on the revenues of gastric cancer drug manufacturers. Similarly, a huge amount is involved in new cancer drug development with a high risk of failure is expected to limit the growth of the gastric cancer drugs market. Drug development involves lot of investment and expenditure, yet the chance of success is minimal. Therefore, prolonged process of development with a high risk of failure also acts as a restraining factor for the gastric cancer drugs market’s growth.

Gastric Cancer Drugs Market Trends

Major trends shaping the gastric cancer drugs market include the following –

Strategic Collaborations And Agreements

Many companies in the gastric cancer drugs market are strategically partnering and collaborating with other companies to broaden their product portfolios and expand their gastric cancer drugs business. These collaborations are helping drug manufacturing companies to enhance their product strength in specific therapy areas. For instance, Basilea Pharmaceutica entered into a clinical trial collaboration and supply agreement with Eli Lilly and Company for the use of the anti-VEGFR2 antibody ramucirumab (CYRAMZA®) 1 in the ongoing multi-cohort phase 1/2 study FIDES-03 with the FGFR inhibitor derazantinib in advanced gastric (stomach) cancer patients with FGFR genetic aberrations.

Global Research Initiatives And Funding

Pharmaceutical companies and federal governments are increasingly working together in partnerships and collaborations to provide funding and implement incentive programs for the research and development (R&D) of gastric cancer drugs. These partnerships provide financial and technical assistance across different clinical development phases to pharmaceutical companies. For example, No Stomach For Cancer funds research that is essential in leading to a cure for stomach cancer and offers funding to support promising stomach cancer research projects worldwide.

Opportunities And Recommendations In Gastric Cancer Drugs Market

Opportunities –The top opportunities in the gastric cancer drugs market segmented by type of gastric cancer drugs will arise in the trastuszumab gastric cancer drugs segment, which will gain $692 million of global annual sales by 2025. The top opportunities in the gastric cancer drugs market segmented by end user will arise in the hospitals segment, which will gain $623 million of global annual sales by 2025. The top opportunities in the gastric cancer drugs market segmented by route of administration will arise in the parenteral segment, which will gain $989.0 million of global annual sales by 2025. The gastric cancer drugs market size will gain the most in USA at $562 million.

Recommendations-To take advantage of these opportunities, The Business Research Company recommends the gastric cancer drugs companies to focus on adopting artificial intelligence technologies, use of CRISPR-Cas9 technology, strategic alliance for research & development, offer bundled payments, expand in emerging markets to gain market share, focus on mergers and acquisitions, use direct-to-marketing approach to maximize reach, utilize big data analytics to improve marketing activities, and target the geriatric population.

Gastric Cancer Drugs Market Segmentation

The gastric cancer drugs market is segmented by type, by end-user and by route of administration.
By Type -
The gastric cancer drugs market is segmented by type into
    • a) Imatnib
    • b) Trastuzumab
    • c) Others
The trastuzumab gastric cancer drugs market was the largest segment of the gastric cancer drugs market segmented by type, accounting for 50.0% of the total in 2020. Going forward, the others segment is expected to be the fastest growing segment in the gastric cancer drugs market segmented by type, at a CAGR of 8.3% during 2020-2025.
By End-User –
The gastric cancer drugs market is segmented by end-user into
    • a) Hospitals
    • b) Clinics
    • c) Cancer Specialty Centers
The hospitals market was the largest segment of the gastric cancer drugs market segmented by end-user, accounting for 44.7% of the total in 2020. Going forward, the cancer specialty centers segment is expected to be the fastest growing segment in the gastric cancer drugs market segmented by end-user, at a CAGR of 4.6% during 2020-2025.
By Route of Administration –
The gastric cancer drug market is segmented by route of administration into
    • a) Oral
    • b) Parental
The parenteral market was the largest segment of the gastric cancer drugs market segmented by route of administration, accounting for 57% of the total in 2020. Going forward, it is expected to be the fastest growing segment in the gastric cancer drugs market segmented by route of administration, at a CAGR of 6.0% during 2020-2025.
By Geography -
The gastric cancer drugs market is segment by geography into
      o Asia Pacific
      • • China
      • • India
      • • Japan
      • • Australia
      • • Indonesia
      • • South Korea
      o North America
      • • USA
      o South America
      • • Brazil
      o Western Europe
      • • France
      • • Germany
      • • UK
      o Eastern Europe
      • • Russia
      o Middle East
      o Africa
North America was the largest region in the global gastric cancer drugs market, accounting for 35.0% of the total in 2020. It was followed by the Asia Pacific and Western Europe and then the other regions. Going forward, the fastest-growing regions in the gastric cancer drugs market will be North America and, Africa where growth will be at CAGRs of 5.7% and 4.4% respectively. These will be followed by Middle East and Asia Pacific, where the markets are expected to register CAGRs of 3.9% and 3.9% respectively.

Gastric Cancer Drugs Competitive Landscape

Major Competitors In The Gastric Cancer Drugs Market Are:

  • F. Hoffmann-La Roche
  • Eli Lilly and Company
  • Otsuka Pharmaceutical
  • Jiangsu HengRui Medicine
  • Biocon
  • Other Competitors In The Gastric Cancer Drugs Market Include:

  • Abbott Laboratories
  • Apikos Pharma
  • AQVIDA GmbH
  • Arlak Biotech
  • Ascedis Health
  • Astellas Pharma Inc
  • AstraZeneca plc
  • Baxter International Inc.
  • BeiGene
  • Biocad
  • BMS
  • Bristol-Myers Squibb
  • CARsgen Therapeutics
  • Celltrion Inc
  • Celnova Pharma
  • Celon Pharma
  • CStone Pharma
  • Daiichi Pharmaceutical
  • Eurofarma Laboratórios S.A.
  • Gilead Sciences
  • GlaxoSmithKline PLC
  • Gulf Pharmaceutical Industries
  • Healthkind labs Pvt. Ltd.
  • Imugene Limited
  • Johnson & Johnson
  • JW Therapeutics
  • Kolaz biotech
  • Merck & Co. Inc.
  • Mylan Laboratories
  • Novartis AG
  • Pfizer Inc.
  • Pierre Fabre Group
  • PV Pharma Healthcare
  • Sankyo
  • Sanofi
  • Saudi Pharmaceutical Industries and Medical Appliances Corporation
  • SwisscheM Healthcare Pvt.Ltd
  • Takeda Pharmaceuticals
  • Teva Pharmaceutical Industries Ltd
  • TUTEUR Argentina
  • Veropharm
    1. Table Of Contents

      1. Gastric Cancer Drugs Market Executive Summary

      2. Table of Contents

      3. List of Figures

      4. List of Tables

      5. Report Structure

      6. Introduction

      6.1.1.Segmentation By Geography

      6.1.2. Segmentation By Type

      6.1.3.Segmentation By End-User

      6.1.4. Segmentation By Route Of Administration

      7. Gastric Cancer Drugs Market Characteristics

      7.1. Market Definition

      7.2. Market Segmentation By Type

      7.2.1. Imatinib

      7.2.2.Trastuzumab

      7.2.3. Others

      7.3. Market Segmentation By End-User

      7.3.1. Hospital

      7.3.2. Clinics

      7.3.3. Speciality Cancer Centers

      7.4. Market Segmentation By Route Of Administration

      7.4.1. Oral

      7.4.2.Parenteral

      8. Gastric Cancer Drugs Market Trends And Strategies

      8.1. Strategic Collaborations And Agreements

      8.2. Global Research Initiatives And Funding

      8.3. Increasing Number Of Pipeline Studies And Drug Development

      8.4. Investment In Artificial Intelligence

      8.5. Development And Increasing Demand For Next Generation Biologics

      8.6. CRISPR-Cas9 Technology Use In Gastric Cancer Treatment

      8.7. Use Of 3D Printing To Test New Drugs

      9. COVID-19 Impact On The Gastric Cancer Drugs Market

      9.1. Clinical Trial Delays

      9.2. Low Usage Of Drugs

      9.3. Supply Chain Issues

      9.4. Shortage In Resources

      10. Global Gastric Cancer Drugs Market Size And Growth

      10.1. Market Size

      10.2. Historic Market Growth, 2015 – 2020, Value ($ Million)

      10.2.1. Drivers Of The Market 2015 – 2020

      10.2.2. Restraints On The Market 2015 – 2020

      10.3. Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      10.3.1. Drivers Of The Market 2020 – 2025

      10.3.2. Restraints On The Market 2020 – 2025

      11. Global Gastric Cancer Drugs Market Segmentation

      11.1.Global Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      11.1.1. Trastuzumab

      11.1.2. Others

      11.1.3. Imatinib

      11.2. Global Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      11.2.1. Hospitals

      11.2.2. Cancer Specialty Centers

      11.2.3. Clinics

      12. Gastric Cancer Drugs Market, Regional And Country Analysis

      12.1. Global Gastric Cancer Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      12.2. Global Gastric Cancer Drugs Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      12.3. Global Gastric Cancer Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      12.3.1. Parenteral

      12.3.2. Oral

      13. Asia-Pacific Gastric Cancer Drugs Market

      13.1.Asia-Pacific Gastric Cancer Drugs Market Overview

      13.1.1. Region Information

      13.1.2. Market Information

      13.1.3. COVID-19 Impact

      13.1.4. Background Information

      13.1.5. Government Initiatives

      13.1.6. Regulations

      13.1.7. Regulatory Bodies

      13.1.8. Major Associations

      13.1.9. Taxes Levied

      13.1.10. Corporate Tax Structure

      13.1.11. Investments

      13.1.12. Major Companies

      13.2. Asia-Pacific Gastric Cancer Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.3.Asia-Pacific Gastric Cancer Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      13.4. Asia-Pacific Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.5.Asia-Pacific Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.6. Asia-Pacific Gastric Cancer Drugs Market: Country Analysis

      13.7. China Gastric Cancer Drugs Market

      13.8. China Gastric Cancer Drugs Market Overview

      13.8.1. Country Information

      13.8.2. Market Information

      13.8.3. COVID-19 Impact

      13.8.4. Background information

      13.8.5. Government Initiatives

      13.8.6. Regulations

      13.8.7. Regulatory Bodies

      13.8.8. Major Associations

      13.8.9. Taxes levied

      13.8.10. Corporate tax structure

      13.8.11. Investments

      13.8.12. Major Companies

      13.9. China Gastric Cancer Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.10. China Gastric Cancer Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      13.11. China Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.12. China Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.13. India Gastric Cancer Drugs Market

      13.14. India Gastric Cancer Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.15. India Gastric Cancer Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      13.16. India Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.17. India Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.18. Japan Gastric Cancer Drugs Market

      13.19. Japan Gastric Cancer Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.20. Japan Gastric Cancer Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      13.21. Japan Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.22. Japan Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.23. Australia Gastric Cancer Drugs Market

      13.24. Australia Gastric Cancer Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.25. Australia Gastric Cancer Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      13.26. Australia Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.27. Australia Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.28. Indonesia Gastric Cancer Drugs Market

      13.29. Indonesia Gastric Cancer Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.30. Indonesia Gastric Cancer Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      13.31. Indonesia Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.32. Indonesia Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.33. South Korea Gastric Cancer Drugs Market

      13.34. South Korea Gastric Cancer Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.35. South Korea Gastric Cancer Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      13.36. South Korea Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.37. South Korea Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14. Western Europe Gastric Cancer Drugs Market

      14.1. Western Europe Gastric Cancer Drugs Market Overview

      14.1.1. Region Information

      14.1.2. Market Information

      14.1.3. COVID-19 Impact

      14.1.4. Background Information

      14.1.5. New Drug Approvals

      14.1.6. Government Initiatives

      14.1.7. Regulations

      14.1.8. Regulatory Bodies

      14.1.9. Major Associations

      14.1.10. Taxes Levied

      14.1.11. Corporate Tax Structure

      14.1.12. Investment

      14.1.13. Major Companies

      14.2. Western Europe Gastric Cancer Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.3. Western Europe Gastric Cancer Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      14.4. Western Europe Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.5. Western Europe Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.6. Western Europe Gastric Cancer Drugs Market: Country Analysis

      14.7.UK Gastric Cancer Drugs Market

      14.8. UK Gastric Cancer Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.9. UK Gastric Cancer Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      14.10. UK Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.11. UK Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.12. Germany Gastric Cancer Drugs Market

      14.13. Germany Gastric Cancer Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.14. Germany Gastric Cancer Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      14.15. Germany Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.16. Germany Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.17. France Gastric Cancer Drugs Market

      14.18. France Gastric Cancer Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.19. France Gastric Cancer Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      14.20. France Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.21. France Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15. Eastern Europe Gastric Cancer Drugs Market

      15.1.Eastern Europe Gastric Cancer Drugs Market Overview

      15.1.1. Region Information

      15.1.2. Market Information

      15.1.3. COVID-19 Impact

      15.1.4. Background Information

      15.1.5. New Drug Approvals

      15.1.6. Government Initiatives

      15.1.7. Regulations

      15.1.8. Regulatory Bodies

      15.1.9. Major Associations

      15.1.10. Taxes Levied

      15.1.11. Corporate Tax Structure

      15.1.12. Investments

      15.1.13. Major Companies

      15.2. Eastern Europe Gastric Cancer Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      15.3.Eastern Europe Gastric Cancer Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      15.4. Eastern Europe Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15.5.Eastern Europe Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15.6. Eastern Europe Gastric Cancer Drugs Market: Country Analysis

      15.7. Russia Gastric Cancer Drugs Market

      15.8. Russia Gastric Cancer Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      15.9. Russia Gastric Cancer Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      15.10. Russia Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15.11. Russia Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      16. North America Gastric Cancer Drugs Market

      16.1. North America Gastric Cancer Drugs Market Overview

      16.1.1. Region Information

      16.1.2. Market Information

      16.1.3. COVID-19 Impact

      16.1.4. Background Information

      16.1.5. New Drug Approvals

      16.1.6. Government Initiatives

      16.1.7. Regulations

      16.1.8. Regulatory Bodies

      16.1.9. Major Associations

      16.1.10. Taxes levied

      16.1.11. Corporate Tax Structure

      16.1.12. Investments

      16.1.13. Major Companies

      16.2. North America Gastric Cancer Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      16.3. North America Gastric Cancer Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      16.4. North America Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      16.5. North America Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      16.6. North America Gastric Cancer Drugs Market: Country Analysis

      16.7.USA Gastric Cancer Drugs Market

      16.8. USA Gastric Cancer Drugs Market Overview

      16.8.1. Region Information

      16.8.2. Market Information

      16.8.3. COVID-19 Impact

      16.8.4. Background Information

      16.8.5. New Drug Approvals

      16.8.6. Government Initiatives

      16.8.7. Regulations

      16.8.8. Regulatory Bodies

      16.8.9. Major Associations

      16.8.10. Taxes levied

      16.8.11. Corporate Tax Structure

      16.8.12. Investment

      16.8.13. Major Companies

      16.9. USA Gastric Cancer Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      16.10. USA Gastric Cancer Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      16.11. USA Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      16.12. USA Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17. South America Gastric Cancer Drugs Market

      17.1. South America Gastric Cancer Drugs Market Overview

      17.1.1. Region Information

      17.1.2. COVID-19 Impact

      17.1.3. Market Information

      17.1.4. Background Information

      17.1.5. New Drug Approvals

      17.1.6. Government Initiatives

      17.1.7. Regulations

      17.1.8. Regulatory Bodies

      17.1.9. Major Associations

      17.1.10. Taxes Levied

      17.1.11. Corporate Tax Structure

      17.1.12. Investments

      17.1.13. Major Companies

      17.2.South America Gastric Cancer Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      17.3. South America Gastric Cancer Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      17.4.South America Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17.5. South America Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17.6.South America Gastric Cancer Drugs Market: Country Analysis

      17.7. Brazil Gastric Cancer Drugs Market

      17.8.Brazil Gastric Cancer Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      17.9.Brazil Gastric Cancer Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      17.10. Brazil Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17.11. Brazil Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      18. Middle East Gastric Cancer Drugs Market

      18.1. Middle East Gastric Cancer Drugs Market Overview

      18.1.1. Region Information

      18.1.2. Market Information

      18.1.3. COVID-19 Impact

      18.1.4. Background Information

      18.1.5. Government Initiatives

      18.1.6. Regulations

      18.1.7. Regulatory Bodies

      18.1.8. Major Associations

      18.1.9. Taxes levied

      18.1.10. Corporate Tax Structure

      18.1.11. Investment

      18.1.12. Major Companies

      18.2. Middle East Gastric Cancer Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      18.3. Middle East Gastric Cancer Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      18.4. Middle East Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      18.5. Middle East Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      19. Africa Gastric Cancer Drugs Market

      19.1. Africa Gastric Cancer Drugs Market Overview

      19.1.1. Region Information

      19.1.2. Market Information

      19.1.3. COVID-19 Impact

      19.1.4. Background Information

      19.1.5. Government Initiatives

      19.1.6. Regulations

      19.1.7. Regulatory Bodies

      19.1.8. Major Associations

      19.1.9. Taxes levied

      19.1.10. Corporate Tax Structure

      19.1.11. Investment

      19.1.12. Major Companies

      19.2. Africa Gastric Cancer Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      19.3. Africa Gastric Cancer Drugs Market, Forecast Market Growth, 2020 – 2025, 2030FValue ($ Million)

      19.4. Africa Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      19.5. Africa Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      20. Global Gastric Cancer Drugs Market Competitive Landscape

      20.1. Company Profiles

      20.2. F. Hoffmann-La Roche Ltd

      20.2.1. Company Overview

      20.2.2. Products And Services

      20.2.3. Financial Overview

      20.3. Eli Lilly And Company

      20.3.1. Company Overview

      20.3.2. Products And Services

      20.3.3. Business Strategy

      20.3.4. Financial Overview

      20.4. Otsuka Pharmaceutical

      20.4.1. Company Overview

      20.4.2. Products And Services

      20.4.3. Business Strategy

      20.4.4. Financial Overview

      20.5. Jiangsu HengRui Medicine

      20.5.1. Company Overview

      20.5.2. Products And Services

      20.5.3. Business Strategy

      20.5.4. Financial Overview

      20.6. Biocon

      20.6.1. Company Overview

      20.6.2. Products And Services

      20.6.3. Business Strategy

      20.6.4. Financial Overview

      21. Gastric Cancer Drugs Pipeline Analysis

      22. Key Mergers And Acquisitions In The Gastric Cancer Drugs Market

      22.1. Compass Therapeutics, Inc. Acquired TRIGR Therapeutics, Inc.

      22.2. Agilent Technologies Acquired Resolution Bioscience

      22.3. Amgen Inc. Acquired Five Prime Technologies

      22.4. Takeda Pharmaceutical Co. Acquired Maverick Therapeutics

      22.5. Pfizer Acquired Array Biopharma

      22.6. Eli Lilly Acquired Loxo Oncology

      23. Gastric Cancer Drugs Market Opportunities And Strategies

      23.1. Global Gastric Cancer Drugs Market In 2025 – Countries Offering Most New Opportunities

      23.2. Global Gastric Cancer Drugs Market In 2025 – Segments Offering Most New Opportunities

      23.3. Global Gastric Cancer Drugs Market In 2025 – Growth Strategies

      23.3.1. Market Trend Based Strategies

      23.3.2. Competitor Strategies

      24. Gastric Cancer Drugs Market, Conclusions And Recommendations

      24.1. Conclusions

      24.2. Recommendations

      24.2.1. Product

      24.2.2. Price

      24.2.3. Place

      24.2.4. Promotion

      24.2.5. People

      25. Appendix

      25.1. Market Data Sources

      25.2. Research Methodology

      25.3. Currencies

      25.4. Research Inquiries

      25.5. The Business Research Company

      25.6. Copyright and Disclaimer

    List Of Tables

      Table 1: Global Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 2: Global Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 3: Global Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 4: Global Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 5: Global Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 6: Global Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 7: Global Gastric Cancer Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 8: Global Gastric Cancer Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 9: Global Gastric Cancer Drugs Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 10: Global Gastric Cancer Drugs Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 11: Global Gastric Cancer Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 12: Global Gastric Cancer Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 13: Asia Pacific GDP Per Capita, 2015-2020, $
    • Table 14: Asia Pacific, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 15: Asia-Pacific Public Healthcare Expenditure, 2015-2019, $ Billion
    • Table 16:  Asia-Pacific Private Healthcare Expenditure, 2015-2019, $ Billion
    • Table 17: Asia-Pacific Healthcare Services Market Size, 2015-2020, $ Billion
    • Table 18: Asia-Pacific Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 19: Asia-Pacific Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 20: Asia-Pacific Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 21: Asia-Pacific Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 22: Asia-Pacific Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 23: Asia-Pacific Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 24: China GDP Per Capita, 2015-2020, $
    • Table 25: China, Population By Age Group, 2015-2023, Thousands
    • Table 26:  China Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion
    • Table 27: China Healthcare Services Market Size, 2015-2020, $ Billion
    • Table 28: China Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 29: China Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 30: China Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 31: China Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 32: China Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 33: China Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 34: India Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 35: India Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 36: India Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 37: India Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 38: India Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 39: India Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 40: Japan Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 41: Japan Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 42: Japan Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 43: Japan Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 44: Japan Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 45: Japan Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 46: Australia Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 47: Australia Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 48: Australia Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 49: Australia Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 50: Australia Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 51: Australia Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 52: Indonesia Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 53: Indonesia Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 54: Indonesia Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 55: Indonesia Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 56: Indonesia Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 57: Indonesia Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 58: South Korea Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 59: South Korea Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 60: South Korea Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 61: South Korea Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 62: South Korea Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 63: South Korea Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 64: Western Europe GDP Per Capita, 2015-2020, $
    • Table 65: Western Europe, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 66:  Western Europe Public Healthcare Expenditure, 2015-2019, $ Billion
    • Table 67:  Western Europe Private Healthcare Expenditure, 2015-2019, $ Billion
    • Table 68: Western Europe Healthcare Services Market Size, 2015-2020, $ Billion
    • Table 69: Western Europe Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 70: Western Europe Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 71: Western Europe Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 72: Western Europe Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 73: Western Europe Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 74: Western Europe Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 75: UK Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 76: UK Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 77: UK Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 78: UK Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 79: UK Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 80: UK Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 81: Germany Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 82: Germany Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 83: Germany Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 84: Germany Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 85: Germany Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 86: Germany Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 87: France Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 88: France Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 89: France Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 90: France Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 91: France Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 92: France Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 93: Eastern Europe GDP Per Capita, 2015-2020, $
    • Table 94: Eastern Europe, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 95:  Eastern Europe Public Healthcare Expenditure, 2015-2019, $ Billion
    • Table 96:  Eastern Europe Private Healthcare Expenditure, 2015-2019, $ Billion
    • Table 97: Eastern Europe Healthcare Services Market Size, 2015-2020, $ Billion
    • Table 98: Eastern Europe Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 99: Eastern Europe Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 100: Eastern Europe Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 101: Eastern Europe Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 102: Eastern Europe Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 103: Eastern Europe Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 104: Russia Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 105: Russia Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 106: Russia Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 107: Russia Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 108: Russia Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 109: Russia Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 110: North America GDP Per Capita, 2015-2020, $
    • Table 111: North America, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 112:  North America Public Healthcare Expenditure, 2015-2019, $ Billion
    • Table 113:  North America Private Healthcare Expenditure, 2013-2017, $ Billion
    • Table 114: North America Healthcare Services Market Size, 2015-2020, $ Billion
    • Table 115: North America Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 116: North America Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 117: North America Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 118: North America Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 119: North America Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 120: North America Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 121: USA GDP Per Capita, 2015-2020, $
    • Table 122: USA, Population By Age Group, 2015-2023, Thousands
    • Table 123:  USA Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion
    • Table 124: USA Healthcare Services Market Size, 2015-2020, $ Billion
    • Table 125: USA Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 126: USA Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 127: USA Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 128: USA Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 129: USA Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 130: USA Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 131: South America GDP Per Capita, 2015-2020, $
    • Table 132: South America, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 133:  South America Public Healthcare Expenditure, 2015-2019, $ Billion
    • Table 134:  South America Private Healthcare Expenditure, 2015-2019, $ Billion
    • Table 135: South America Healthcare Services Market Size, 2015-2020, $ Billion
    • Table 136: South America Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 137: South America Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 138: South America Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 139: South America Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 140: South America Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 141: South America Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 142: Brazil Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 143: Brazil Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 144: Brazil Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 145: Brazil Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 146: Brazil Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 147: Brazil Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 148: Middle East GDP Per Capita, 2015-2020, $
    • Table 149: Middle East, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 150:  Middle East Public Healthcare Expenditure, 2015-2019, $ Billion
    • Table 151:  Middle East Private Healthcare Expenditure, 2015-2019, $ Billion
    • Table 152: Middle East Healthcare Services Market Size, 2015-2020, $ Billion
    • Table 153: Middle East Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 154: Middle East Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 155: Middle East Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 156: Middle East Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 157: Middle East Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 158: Middle East Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 159: Africa GDP Per Capita, 2015-2020, $
    • Table 160: Africa, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 161:  Africa Public Healthcare Expenditure, 2015-2019, $ Billion
    • Table 162:  Africa Private Healthcare Expenditure, 2015-2019, $ Billion
    • Table 163: Africa Healthcare Services Market Size, 2015-2020, $ Billion
    • Table 164: Africa Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 165: Africa Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 166: Africa Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 167: Africa Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 168:AfricaGastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 169:AfricaGastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 170: Global  Gastric Cancer Drugs Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
    • Table 171: F. Hoffmann-La Roche Ltd – Financial Overview, 2016 - 2020, $ Billion
    • Table 172: Eli Lilly And Company –  Financial Overview, 2016 - 2020, $ Billion
    • Table 173: Otsuka Pharmaceutical – Financial Overview, 2015 - 2019, $ Million
    • Table 174: Jiangsu HengRui Medicine – Financial Overview, 2016 - 2020, $ Billion
    • Table 175: Biocon – Financial Overview, 2016 - 2020, $ Billion
    • Table 176: Global Gastric Cancer Drugs Market, Pipeline Analysis
    • Table 177: Global Gastric Cancer Drugs Market Size Gain ($ Million), 2020 – 2025, By Country
    • Table 178: Global Gastric Cancer Drugs Market Size Gain ($ Million), Segmentation By Type, 2020 – 2025
    • Table 179: Global Gastric Cancer Drugs Market Size Gain ($ Million), Segmentation By End User, 2020 – 2025
    • Table 180: Global Gastric Cancer Drugs Market Size Gain ($ Million), Segmentation By End User, 2020 – 2025

    List Of Figures

      Figure 1: Global Gastric Cancer Drugs Market Segmentation By Type
    • Figure 2: Global Gastric Cancer Drugs Market Segmentation By End-User
    • Figure 3: Global Gastric Cancer Drugs Market Segmentation By Route Of Administration
    • Figure 4: Global Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 5: Global Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 6: Global Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 7: Global Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 8: Global Gastric Cancer Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 9: Global Gastric Cancer Drugs Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 10: Global Gastric Cancer Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 11: Asia-Pacific Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 12: Asia-Pacific Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 13: Asia-Pacific Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 14: Asia-Pacific Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 15: China Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 16: China Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 17: China Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 18: China Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 19: India Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 20: India Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 21: India Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 22: India Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 23: Japan Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 24: Japan Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 25: Japan Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 26: Japan Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 27: Australia Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 28: Australia Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 29: Australia Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 30: Australia Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 31: Indonesia Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 32: Indonesia Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 33: Indonesia Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 34: Indonesia Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 35: South Korea Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 36: South Korea Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 37: South Korea Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 38: South Korea Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 39: Western Europe Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 40: Western Europe Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 41: Western Europe Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 42: Western Europe Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 43: UK Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 44: UK Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 45: UK Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 46: UK Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 47: Germany Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 48: Germany Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 49: Germany Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 50: Germany Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 51: France Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 52: France Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 53: France Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 54: France Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 55: Eastern Europe Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 56: Eastern Europe Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 57: Eastern Europe Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 58: Eastern Europe Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 59: Russia Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 60: Russia Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 61: Russia Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 62: Russia Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 63: North America Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 64: North America Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 65: North America Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 66: North America Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 67: USA Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 68: USA Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 69: USA Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 70: USA Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 71: South America Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 72: South America Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 73: South America Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 74: South America Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 75: Brazil Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 76: Brazil Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 77: Brazil Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 78: Brazil Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 79: Middle East Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 80: Middle East Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 81: Middle East Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 82: Middle East Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure83: Africa Gastric Cancer Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 84: Africa Gastric Cancer Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 85: Africa Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 86: Africa Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 87: Global  Gastric Cancer Drugs Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
    • Figure 88: F. Hoffmann-La Roche Ltd – Financial Overview, 2016 – 2020, $ Billion
    • Figure 89: Eli Lilly And Company – Financial Overview 2016 – 2020, $ Billion
    • Figure 90: Otsuka Pharmaceutical – Financial Overview, 2015 – 2019, $ Million
    • Figure 91: Jiangsu HengRui Medicine – Financial Overview, 2016 – 2020, $ Billion
    • Figure 92: Biocon – Financial Overview, 2016 – 2020, $ Billion
    Global Psoriasis Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global Psoriatic Arthritis Treatment Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global Regenerative Medicine For Cartilage Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global Radiopharmaceuticals Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global Remdesivir Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global Research Antibodies and Reagents Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global Rituximab Biosimilars Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global Respiratory Diseases Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Dry Eye Medication Market - By Prescription Type (OTC Drugs, Prescription Drugs) By Drug Variation (Branded, Generic) By Type Of Product (Aqueous, Evaporative, Aqueous and Evaporative) By Distribution Channel (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies) By Delivery System (Liquid, Gel, Ointment, Others) And By Region, Opportunities And Strategies – Global Forecast To 2030
    View Report
    Ophthalmology Drugs Market - By Type (Antglaucoma Drugs, Dry Eye Medication And Other Ophthalmological Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores And Others), By Drug Classification (Branded Drugs And Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) And, By Region, Opportunities And Strategies – Global Forecast To 2030
    View Report
    Pharmaceutical Drugs Market - By Segments (Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2030
    View Report
    Musculoskeletal Drugs Market Global Briefing 2018
    View Report
    Respiratory Drugs Market Global Briefing 2018
    View Report
    Antisense And RNAi Therapeutics Market- By Technology (RNA Interference, Antisense RNA), By Route Of Administration (Intravenous injections, Intra Dermal injunctions, Other delivery methods), By Indication (Oncology, Cardiovascular device, Respiratory disorders, Neurological disorders, Infectious disease, Other diseases), And By Region, Opportunities And Strategies – Global Forecast To 2030
    View Report
    Diabetes Therapies Market - By Segments (Injectables And Oral), Trends, Key Players, Opportunities And Strategies – Global Forecast To 2023
    View Report
    Global Biologics Market - By Type (Monoclonal Antibodies, Therapeutic Proteins, Vaccines), By Route Of Administration (Oral, Others (IV or IP)), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription Drugs, OTC Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), And By Region, Opportunities And Strategies – Global Forecast To 2023
    View Report

    Call Us

    +1 3156230293

    (Americas)

    +44 2071930708

    (Europe)

    +91 8897263534

    (Asia & Others)